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ORIGINAL ARTICLE
Cumulative use of salivary markers with an adaptive design improves detection
of periodontal disease over fixed biomarker thresholds
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aPeriodontology, Institute of Dentistry, University of Turku, Turku, Finland; bOral and Maxillofacial Diseases, Faculty of Medicine, University of
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ABSTRACT
Objective: Aim was to analyze the diagnostic ability of cumulative risk score (CRS), which uses salivary
levels of Porphyromonas gingivalis, interleukin (IL)-1b, and matrix metalloproteinase (MMP)-8 in an
adaptive design, compared to previously reported thresholds of each marker alone.
Materials and Methods: Oral and general health information of 463 participants were included in the
analysis. Having the percentage of bleeding on probing (BOP)> 25%, having at least two sites with
probing pocket depth (PPD) of 4–5mm or having at least one tooth with alveolar bone loss (ABL) of at
least 1/3 of the root length were accepted as outcome variables. Being above the salivary threshold
concentrations of P. gingivalis, IL-1b, and MMP-8 and CRS values were used as explanatory variables.
Receiver operating characteristics (ROC) producing an area under the curve (AUC) and multinomial
regression analysis were used in statistical analysis.
Results: CRS provided AUCs larger than any other tested biomarker threshold. Sensitivity and specifi-
city of CRS for detecting clinical markers of periodontitis were acceptable, and a strong association was
observed between the highest CRS score and having at least two sites with PPD of 4–5mm.
Conclusion: CRS brings additional power over fixed thresholds of single biomarkers in detecting
periodontitis.
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Introduction
Periodontitis is a chronic infection-induced inflammatory
disease, where bacteria or their by-products induce an
inflammatory host response around the tooth. Chronic
inflammation of tooth-supporting tissues progresses slowly
and is usually symptomless. However, in susceptible subjects,
uncontrolled chronic inflammation may cause extensive
alveolar bone degradation and lead to tooth loss [1].
Specific host- or bacteria-derived biomarkers detected in
saliva indicate the presence or progression/remission of peri-
odontitis. With the aid of Omics Technologies, search for bio-
markers with high sensitivity and specificity has broadened
during the last decade [2]. The use of a single salivary marker
in detection of periodontitis is, however, challenged by the
episodic and multi-factorial characteristics of the disease [3].
In addition, diversities in sample collection, storage, and ana-
lysis techniques cause significant variations in the concentra-
tions of selected biomarkers in saliva [4]. These variations
limit the assignment of a fixed universal threshold for a saliv-
ary biomarker in detecting periodontitis. Indeed, a combin-
ational use of salivary biomarker panels produces more
robust outcomes in periodontal disease prediction [5]. Our
group developed a novel diagnostic approach, namely
Cumulative Risk Score (CRS), in which we analyze concentra-
tions of three selected biomarkers representing periodontal
pathogen burden (Porphyromonas gingivalis), inflammation
(interleukin (IL)-1b), and tissue destruction (matrix
metalloproteinase (MMP)-8) [6]. In calculation of CRS, salivary
concentrations of P. gingivalis, IL-1b, and MMP-8 are divided
into tertiles and cumulative sub-score of each individual is
calculated by the multiplication of the tertile values.
Distribution of study population into tertiles allows CRS to
take into account concentration ranges of the biomarkers
and, in addition, to use an adaptive design to allocate study
subjects in three risk groups (high, middle, low) for the pres-
ence of periodontitis. The CRS model was originally intro-
duced in a subpopulation (n¼ 165) of the National Health
2000 Health Examination Survey in Finland. The CRS
was later validated in a cohort study including 493 Finnish
adults [7].
In determination of a cut-off threshold for a biomarker,
receiver operating characteristics (ROC) curve is commonly
used. According to this method, the point on the ROC curve,
which has the minimum distance to the point where sensitiv-
ity and specificity is equal to one, is taken as the cut-off
value. Another approach is to take the value, which maxi-
mizes the distance between the ROC curve and reference
(random) line [8]. While these methods are commonly used
in biomarker studies, the diagnostic power of the selected
cut-off is highly dependent on the measured concentration
range of the biomarker and the prevalence of the disease in
the study population. Moreover, the diagnostic performance
of the biomarker is usually exaggerated by the data-driven
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choice of a cut-off [9]. Therefore, there is an indisputable
need of a validation study where the diagnostic power of the
cut-off is tested in an independent population. P. gingivalis,
IL-1b, and MMP-8 are among the most widely tested salivary
biomarkers of periodontitis and several cut-off values are pre-
sented in different studies [10–14]. However, to our know-
ledge, none of these cut-off values are validated in an
independent study. Here, we hypothesized that cumulative
use of salivary markers with an adaptive design has superior-
ity over fixed biomarker thresholds in detection of periodon-
tal disease. To test this hypothesis, in the present study, the
strength of CRS’s diagnostic ability was tested against previ-
ously defined thresholds of P. gingivalis, IL-1b, and MMP-8.
Materials and methods
Definition for salivary thresholds of P. gingivalis, IL-1b,
and MMP-8
A Medline search was performed using keywords ‘P.
gingivalis’, ‘IL-1b’, and ‘MMP-8’ together with ‘salivary’ or
‘saliva’, and ‘threshold’. In the present analysis, the following
studies defining the salivary thresholds of P. gingivalis, IL-1b,
and MMP-8 to discriminate periodontally diseased subjects
from healthy ones were included:
 P. gingivalis: 5 105 cells/ml [10]
 IL-1b: 28 pg/ml [11]; 212 pg/ml [12]; 235 pg/ml [13]
 MMP-8: 87 ng/ml [13]; 140 ng/ml [11]; 383 ng/ml [14].
Study participants
Oral and general health information of 463 dentate patients
of Parogene study were included in the present analyses.
The Parogene study was approved by the Helsinki University
Central Hospital ethics committee (#106/2007). A detailed
description of the study design can be found elsewhere [12].
Briefly, oral examination included the probing pocket depth
(PPD) and bleeding on probing (BOP) measurements from all
teeth. Alveolar bone loss (ABL) was measured from digital
panoramic radiographs by choosing the tooth with most
severe attachment loss from each dentate sextant and
graded into four categories by calculating the mean of the
sextants: no ABL; ABL in the cervical third of the root; ABL in
the middle third of the root; and ABL from the apical third of
the root to total ABL [15].
Paraffin-stimulated salivary samples were collected before
the oral examinations and stored at 70 C until laboratory
analyses. Before the analysis, samples were thawed and cen-
trifuged at 9300 g for 5minutes. The pellet was used for the
P. gingivalis measurement and the supernatant for the IL-1b
and MMP-8 determinations. IL-1b concentrations were meas-
ured with a flow cytometry-based Luminex technique with
commercially available kits (Milliplex Map Kit; MPXHCYTO-
60k, Millipore, Billerica, MA, USA). MMP-8 concentrations
detected with a time-resolved immunofluorometric assay and
P. gingivalis concentrations with qPCR, as described previ-
ously in detail [7,16].
Cumulative risk score
The CRS score of each subject was calculated as follows:
P. gingivalis, 1: No P. gingivalis; 2: below the median
value (12–1639 genome/ml); 3: above the median value
(1678–1.2 107 genome/ml).
IL-1b, 1: the lowest tertile (0.01–12.21 pg/ml); 2: mid-tertile
(12.22–50.43 pg/ml); 3: highest tertile (50.94–1351 pg/ml).
MMP-8, 1: the lowest tertile (1–641 ng/ml); 2: mid-tertile
(643–1251 ng/ml); 3: highest tertile (1258–3580 ng/ml).
The cumulative sub-score of each subject was calculated
by multiplication of the three tertile values. The final CRS
groups were formed according to the sub-scores: CRS I, indi-
cating the lowest risk of carrying periodontitis (the cumula-
tive sub-scores of 1, 2, and 3); CRS II, indicating middle risk
of carrying periodontitis (the cumulative sub-scores of 4, 6, 8,
and 9); and CRS III, indicating the highest risk of carrying
periodontitis (the cumulative sub-scores of 12, 18, and 27).
Statistical analysis
The statistical analysis was performed with IBM SPSS
Statistics (version 22; IBM Corp. Armonk, NY, USA). Having
BOP>25%, having at least two sites with PPD of 4–5mm, or
having at least one tooth with ABL of at least 1/3 of the root
length were accepted as outcome variables. The CRS values
and being above the thresholds of P. gingivalis, IL-1b, and
MMP-8 were used as explanatory variables. When the
selected thresholds (presented above) of these biomarkers
were used in the ROC analysis as screening measures, con-
tinuous variables of P. gingivalis, IL-1b, and MMP-8 values
were converted into a dichotomous variable of ‘below the
threshold’ – ‘0’, and ‘above the threshold’ – ‘1’.
Outcome variables are used in conjunction with explana-
tory variables in a diagnostic matrix to calculate specificity
and specificity. ROC and area under the curve (AUC) analyses
were calculated for the discriminative efficacy of each thresh-
old and CRS.
Multinomial regression analyses were performed to
describe the associations between outcome and explanatory
variables, after adjusting for smoking, gender, and age.
Statistical significance was defined as p< .05.
Results
Figure 1 presents the ROC curves and AUCs. The CRS distin-
guished the subjects having at least two sites with PPD of
4–5mm and provided an AUC of 0.725. The IL-1b at concen-
trations of 28 pg/ml and 212pg/ml distinguished subjects
with BOP>25% with AUCs of 0.562 and 0.542, respectively.
MMP-8 at concentration of 383 ng/ml and IL-1b at concentra-
tions of 28 pg/ml distinguished subjects with having at least
two sites with PPD of 4–5mm with AUCs of 0.618 and 0.663,
respectively. The sensitivity and specificity of CRS for detect-
ing periodontitis were high, especially when CRS II (middle
risk) and CRS III (high risk) were combined and compared to
CRS I (low risk) (Table 1). The strongest association among
the outcome and explanatory variables was observed
between CRS III (high risk) and having at least two sites with
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PPD of 4–5mm presenting an odds ratio (95% CI) of 8.9
(2.6–30.4), p< .001 (Table 2).
Discussion
In the present analyses, CRS brings additional diagnostic
power over single biomarker thresholds in detection of
periodontitis. The CRS does not apply fixed thresholds to
dichotomize the population as periodontitis patients and
non-periodontitis individuals, instead, it distributes the sub-
jects into the high-, middle-, and low-risk groups according
to the variations of biomarker levels within the ranges of
their concentrations. This approach takes into account the
biomarker dynamics and minimizes discrepancies in the
results due to methodological differences between studies.
On one hand, single cut-offs are commonly used in clinical
studies to dichotomize the study population into healthy and
diseased. On the other hand, recent evidence demonstrates
that use of two cut-offs, one corresponding to certainty of
diagnostic inclusion and one corresponding to certainty of
diagnostic exclusion, is more useful in clinical setting [8].
According to the two cut-off method, when a value of a
Figure 1. Receiver operating characteristics (ROC) analysis of each salivary biomarker threshold and CRS. For each threshold published, a new dichotomous variable
of ‘below the threshold’ – ‘0’, and ‘above the threshold’ – ‘1’ was calculated and used as a screening variable. Area under the curve (95% confidence intervals) and
p values from the ROC analyses are given.
Table 1. Sensitivities and specificities of each threshold and CRS score, in diagnosis of having BOP >25%, having at least two sites with PPD of 4–5mm or hav-
ing at least one tooth with ABL of at least 1/3 of the root length.
BOP>25% 2 Sites with 4–5mm PPD ABL at least 1/3 of the root
Threshold Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity
P.g. (O’Brien-Simpson et al. [10] 5 105 cells/ml 12.8 91.3 12.7 95.6 13.6 95.5
IL-1b (Ebersole et al. [11] 28 pg/ml 52.5 59.8 53.5 79.0 49.2 52.4
IL-1b (Sanchez et al. [12] 212 pg/ml 14.8 94.5 13.8 98.4 14.0 94.2
IL-1b (Ramseier et al. [13] 235 pg/ml 14.4 96.1 13.0 98.4 13.1 94.2
MMP-8 (Ramseier et al. [13] 87 ng/ml 95.8 8.7 95.9 14.7 94.6 6.4
MMP-8 (Ebersole et al. [11] 140 ng/ml 93.9 14.1 93.4 20.6 91.8 10.1
MMP-8 (Gursoy et al. [14] 383 ng/ml 84.9 31.5 83.2 41.2 80.7 23.9
CRS III 31.1 77.9 32.2 93.5 31.0 79.8
II–III 72.2 44.9 72.7 66.1 69.3 39.8
Table 2. Associations of salivary biomarkers and CRS with clinical outcomes. All analyses are adjusted for age, gender, and smoking.
BOP>25% 2 Sites with 4–5mm PPD ABL at least 1/3 of the root
Reference OR (95% CI), p OR (95% CI), p OR (95% CI), p
P.g. (O’Brien–Simpson et al. [10] Below threshold 1.5 (0.8–2.9), .251 6.3 (0.8–47.4), .074 2.0 (0.7–5.5), .161
IL-1b (Ebersole et al. [11] Below threshold 1.6 (1.1–2.5), .025 3.2 (1.5–6.9), .002 1.4 (0.8–2.3), .191
IL-1b (Sanchez et al. [12] Below threshold 3.1 (1.3–7.0), .008 6.3 (0.8–47.4), .072 3.6 (1.4–9.4), .008
IL-1b (Ramseier et al. [13] Below threshold 4.3 (1.6–11.1), .003 6.0 (0.8–44.9), .081 3.2 (1.2–8.1), .017
MMP-8 (Ramseier et al. [13] Below threshold 2.3 (0.9–5.0), .052 2.9 (1.1–8.1), .036 2.1 (0.8–5.5), .130
MMP-8 (Ebersole et al. [11] Below threshold 2.7 (1.4–5.3), .004 2.8 (1.1–6.8), .023 1.8 (0.8–4.1), .133
MMP-8 (Gursoy et al. [14] Below threshold 2.6 (1.6–4.2), <.001 2.8 (1.4–5.4), .003 1.8 (1.0–3.2), .047
CRS III CRS I 2.2 (1.2–3.8), .005 8.9 (2.6–30.4), <.001 2.3 (1.2–4.4), .015
CRS II–III CRS I 2.1 (1.4–3.2), .001 4.2 (2.1–8.2), <.001 1.9 (1.1–3.2), .017
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biomarker falls into the gray zone between two cut-offs, the
patient is directed to a physician to be diagnosed with add-
itional tools [8]. The CRS method applies a similar
approach and defines the subjects’ periodontitis risk level to
guide patients to get a clinical diagnosis and periodontal
treatment.
The thresholds used in this study are not necessarily sug-
gested in their original publications as functional thresholds
to discriminate periodontitis patients from periodontally
healthy individuals. The present study included all available
thresholds in the literature regardless of their diagnostic
strength. On the other hand, some thresholds with higher
sensitivity and specificity values were presented in the ori-
ginal reports, in comparison to the present results. One rea-
son behind this finding can be the definition of outcome
variables and diagnostic criteria that defines periodontitis. In
the study by O’Brien–Simpson et al. [10], the individuals with
at least one deepened pocket (PPD5mm) in each quadrant
were recruited in chronic periodontitis group, while Ramseier
and his co-workers [13] defined the periodontitis group as
‘subjects with at least four sites with evidence of alveolar
bone loss, at least four sites with attachment loss>3mm,
and at least four sites with PPD >4mm’. Gursoy et al. [14]
defined the generalized periodontitis group as subjects
having at least 14 teeth with PPD 4mm. For the present
analyses, we grouped the subjects based on clinical measure-
ments representing the important stages of periodontal dis-
ease pathogenesis, namely elevated gingival inflammation
(BOP>25%), deepened periodontal pockets (at least two sites
with PPD of 4–5mm), and alveolar bone loss (ABL, at least 1/
3 of the root length), as outcome variables. This approach
allowed us to analyze the power of each biomarker and CRS
at different stages of the disease.
The CRS method supports the idea of assigning study
population-based thresholds with a more personalized
approach, instead of using universal thresholds [17]. It was
observed that, there are four- to nine-fold differences between
the levels of given thresholds in studies using different meth-
ods for these biomarker determinations [10–14]. This observa-
tion clearly demonstrates that the application of a single
universal threshold is cumbersome and not applicable.
However, a chair-side test may solve the problem, as it will
standardize the methods for saliva collection and biomarker
analyses [18]. The main shortcoming of the CRS method is
due to the requirement of heterogeneous study populations.
For example, homogenous population cohorts, such as army
recruits (males with age range of 18–20 years), will limit CRS’s
ability to create the high-, middle-, and low-risk groups.
Adaptive-threshold designs have gained interest in various
fields of medicine as they may bring on increased power
over fixed thresholds [17]. In the limits of the present study,
we conclude that the cumulative use of salivary P. gingivalis,
IL-1b, and MMP-8 levels with an adaptive design brings add-
itional power over fixed thresholds of single biomarkers in
detecting periodontitis.
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